A top staffer on the House Energy and Commerce Committee says the committee did not pursue a streamlined Medicare coverage provision for breakthrough devices in the latest draft of its 21st Century Cures bill because of "cost implications."
Clay Alspach, chief health counsel on the committee, spoke to industry leaders on April 30 at the Medical Device Manufacturers Association annual meeting in Washington, D.C. While he said the...